Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, Fuchu-shi, Tokyo 183-8509, Japan.
Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, Gifu-shi, Gifu 501-1193, Japan.
Toxicol Sci. 2017 Sep 1;159(1):211-223. doi: 10.1093/toxsci/kfx131.
We previously observed downregulation of mitochondrial oxidative phosphorylation-related protein, TMEM70, which is suggestive of disrupted cellular senescence, in GST-P-expressing (+) proliferative lesions from early hepatocarcinogenesis stages in rats. The present study investigated the immunohistochemical relationship between TMEM70 downregulation and cellular metabolic changes in carcinogenic processes, as well as the onset of the liver cell respiratory changes after repeated hepatocarcinogen treatment in rats. At the early hepatocarcinogenesis stage in a 2-stage model, GST-P+ preneoplastic lesions showing TMEM70 downregulation also downregulated the mitochondrial ATPase, ATPB, but upregulated glycolysis-related glucose transporter member 1 (GLUT1) and glucose-6-phosphate dehydrogenase, suggesting a metabolic shift from oxidative phosphorylation to glycolysis, known as the Warburg effect. Combined downregulation of TMEM70 and ATPB increased proliferation activity in GST-P+ preneoplastic lesions, suggesting cell proliferation facilitation by reducing mitochondrial respiration. Concurrent GLUT1-upregulation and TMEM70-downregulation increased nuclear phosphorylated c-MYC+ cells in GST-P+ preneoplastic lesions, suggesting c-MYC-mediated transcription facilitation to promote glycolysis and cell proliferation. The TMEM70-related metabolic shift was enhanced in GST-P+ neoplastic lesions, suggesting a contribution to tumor progression. Conversely, the TMEM70-related metabolic shift was lacking in peroxisome proliferator-activated receptor-α agonist-induced hepatocarcinogenesis, as well as in carcinogenic processes targeting other organs. Transcript expression analysis following 28- and 90-day repeated hepatocarcinogen treatment showed downregulation of Tmem70 from day 28 and upregulation of Pkm and Myc at day 90, suggesting early onset of a catastrophic cellular senescence-related metabolic shift beginning from depressed mitochondrial respiration in the liver. These results suggest a contribution of TMEM70 downregulation to the Warburg effect, which directs tumor promotion and progression in GST-P+-linked hepatocarcinogenesis in rats.
我们之前观察到,在大鼠肝癌发生早期的 GST-P 表达(+)增殖性病变中,线粒体氧化磷酸化相关蛋白 TMEM70 的表达下调,这表明细胞衰老受到干扰。本研究探讨了 TMEM70 下调与致癌过程中细胞代谢变化之间的免疫组织化学关系,以及大鼠重复给予肝癌致癌物后肝细胞呼吸变化的起始。在两阶段模型的早期肝癌发生阶段,显示 TMEM70 下调的 GST-P+癌前病变也下调了线粒体 ATP 酶 ATPB,但上调了糖酵解相关葡萄糖转运蛋白 1 (GLUT1) 和葡萄糖-6-磷酸脱氢酶,表明从氧化磷酸化向糖酵解的代谢转变,即众所周知的沃伯格效应。TMEM70 和 ATPB 的联合下调增加了 GST-P+癌前病变中的增殖活性,提示通过减少线粒体呼吸来促进细胞增殖。同时 GLUT1 的上调和 TMEM70 的下调增加了 GST-P+癌前病变中的核磷酸化 c-MYC+细胞,提示 c-MYC 介导的转录促进以促进糖酵解和细胞增殖。TMEM70 相关的代谢转变在 GST-P+肿瘤病变中得到增强,提示其对肿瘤进展的贡献。相反,在过氧化物酶体增殖物激活受体-α激动剂诱导的肝癌发生以及针对其他器官的致癌过程中,缺乏 TMEM70 相关的代谢转变。在重复给予肝癌致癌物 28 天和 90 天后的转录表达分析显示,Tmem70 从第 28 天开始下调,Pkm 和 Myc 从第 90 天开始上调,提示从肝脏线粒体呼吸下降开始,早期出现灾难性细胞衰老相关代谢转变。这些结果表明 TMEM70 下调对沃伯格效应的贡献,该效应指导大鼠 GST-P+相关肝癌发生中的肿瘤促进和进展。